DNA vaccine strategies for hepatitis C

Journal of Hepatology

Volumn 30, Issue 2, 1999, Pages 339-346

  Inchauspé, Geneviève ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VACCINE; VIRUS DNA;

ANTIBODY RESPONSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PLASMID; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0032915550     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80084-1     Document Type: Review

References (44)

1. Seeff LB. Natural history of hepatitis C. Hepatology. 26:(suppl 1):1997;21S-28S.
2. Cahour A. Les perspectives d'un vaccin contre l'hépatite C: quelle stratégie adopter? Médecine Science. 11:1995;81-91.
3. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258:1992;135-140.
4. Prince AM, Brotman B, Huima T, Pascual D, Jaffrey M, Inchauspé G. Imnunity in hepatitis C virus infection. J Infect Dis. 165:1992;438-443.
5. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 343:1994;338-390.
6. Weiner AJ, Geysens HM, Christopherson C, Hall EJ, Mason TJ, Saracco G, et al. Evidence of immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA. 89:1992;3468-3472.
7. Weiner AJ, Brauer MJ, Rosemblatt J, Richman KH, Tung J, Crawford K. Variable and hypervariable domains are found in the regions of HCV corresponding to flavivirus envelope and NS1 proteins and the pestivirus envelope proteins. Virology. 180:1991;842-848.
8. Farci P, Shimoda A, Wong D, Cabezon T, De Gionnis D, Srazzera A, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA. 93:1996;15394-15399.
9. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, et al. Genetic drift in hypervariable region I of the viral genome in persistent hepatitis C virus infection. J Virol. 68:1994;4776-4784.
10. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K Shimotohno K. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer. 57:1994;664-670.
11. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.
12. Rosa D, Campagnoli S, Moretto C, Cuenzi E, Cousens L, Chin M, et al. A quantitative test to estimate neutralizing antibodies to hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA. 93:1996;1759-1763.
13. Rosa D, Ishii K, Miyamura T, Houghton M, Abrigiani S. High titers of envelope neutralizing antibodies correlate with both prevention of HCV infection and resolution of chronic hepatitis C. Abstract In Fourth International Meeting on Hepatitis C Virus and Related Viruses. Kyoto, Japan 1997; March 6-10.
14. Koshy R, Inchauspé G. Evaluation of hepatitis C virus protein epitopes for vaccine development. Trends in Biotechnology. 14:1996;365-369.
15. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unumaaz D, Weiner AJ, et al. T-lymphocyte response to hepatitis C virus in clinical courses of infection. Gastroenterology. 104:1993;580-587.
16. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, et al. T cell response to structural and non-structural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infection. Hepatology. 19:1994;286-295.
17. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
18. Wang B, Ugen KE, Srkantan V, Agadjanyan MG, Dang K, Refaeli Y, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
19. Davis HL, Michel LM, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet. 3:1993;1847-1851.
20. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Nall Acad Sci USA. 91:1994;9519-9523.
21. Torres CAT, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol. 158:1997;4529-4532.
22. Higashi Y, Kakumi S, Yoshioka K, Wakita T, Mizokarni M, Ohba K, et al. Dynamics change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 197:1993;659-668.
23. Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol. 45:1995;415-422.
24. Hattori M, Yoshioka K, Aiyama T, Iwata K, Terazama Y, Ishigami M, et al. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patients sera: relation to viral loads and response to interferon. Hepatology. 27:1998;1703-1710.
25. Abrigani S. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol. 19:1997;47-55.
26. Tedeschi V, Akatsuka T, Wai-Kuo Shih J, Battegay M, Feistone SE. A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology. 25:1997;459-462.
27. Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J, Fournillier A, et al. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol. 71:1997;7101-7109.
28. Fournillier A, Nakano I, Vitvitski L, Depla E, Vidalin O, Maertens G, et al. Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes. Hepatology. 28:1998;237-244.
29. Stingl G, Tschachler E, Groh V, Wolff K, Hauser C. The immune functions of epidermal cells. Immunol Ser. 4:1989;3-72.
30. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral-cell mediated immune responses. J Clin Invest. 98:1996;706-714.
31. Pertner TM, Roberts TR, Haynes JR. Influenza virus nucleop-rotein-specific immunoglobuloin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol. 70:1996;6119-6125.
32. Saito T, Sherman GJ, Kurokohchi K, Guo Z-P, Donets M, Yu M-YW, et al. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology. 112:1997;7101-7109.
33. Dietzschold B, Wang H, Rupprecht CE, Celis E, Tollis M, Ertl H, et al. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA. 84:1987;9165-9169.
34. Iwarson S, Tabor E, Thomas HC, Snoy P, Gerety RJ. Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastrocnterology. 88:1985;763-767.
35. Major MM, Vivitski L, Mink MA, Schleef M, Whalen RG, Trépo C, et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol. 69:1995;5798-5805.
36. Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol. 69:1995;5859-5863.
37. Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR, et al. Expression and immune response to hepatitis C virus core DNA based vaccine constructs. Hepatology. 24:1996;14-20.
38. Inchauspé G, Vitviski L, Major ME, Jung G, Spengler U, Maisonnas M, et al. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid comparative studies of antibody and T-helper responses following genetic immunization. DNA and Cell Biology. 16:1997;185-195.
39. Geissler M, Tokushige K, Wakita T, Zurawski V, Wands JR. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. Vaccine. 16:1998;857-867.
40. Delpeyroux F, Chenciner N, Lim A, Malpiece Y, Blondel B, Crainic R, et al. A poliovirus neutralizing epitope expressed on hybrid hepatitis B surface antigen particles. Sciences. 233:1986;472-475.
41. Geissler M, Gesein A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 158:1997;1231-1237.
42. Dubuisson HJ, Hsu H, Cheung RC, Greenberg HB, Russell DC, Rice CM. Formation and intraccllular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol. 68:1994;6147-6160.
43. Dubuisson J, Rice C M. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexi. J Virol. 70:1996;778-786.
44. Lavanchy D. W.H.O. point of view on viral hepatitis C in the world. Abstract In: V International Congress on "The Prevention of Liver Diseases on the Threshold of the Third Millennium" Capri. May, 1998;21-23.